America
Novavax Covid-19 vaccine Adjuvanted gets expanded approval in US
Washington, Aug 21
Novavax says the US Food and Drug Administration (FDA) has granted expanded emergency use authorisation for its Covid-19 vaccine Adjuvanted for adolescents aged between 12-17 years.
The US company said the vaccine was the first protein-based Covid-19 jab authorised in the US, dpa news agency reported.
Doses of the Adjuvanted are available for use in adolescents upon the Centers for Disease Control and Prevention's (CDC) recommendation, the company noted.
In July 2022, the FDA had granted emergency use authorisation for a two-dose primary series in adults aged 18 years and older, followed by a recommendation from the CDC Advisory Committee on Immunisation Practices, and endorsement from the CDC.
14 hours ago
Mumbai hoarding crash rescue operation ends after 60 hours; rubble clearance work underway
14 hours ago
Five Israeli soldiers killed in Gaza by errant Israeli tank shelling
14 hours ago
Sudan denies reports of visa denial to US envoy
17 hours ago
New Leadership Sworn In by Federation of Indian Associations Chicago
17 hours ago
India-American investor and two others appointed to OneStar Foundation by Texas Governor
17 hours ago
Extended stay in the US allowed for laid-off H-1B workers
17 hours ago
House members in the United States have introduced bills to codify the country's approach to the Indian Ocean.
18 hours ago
United Nations: One-Third Increase in Youth Attempting Perilous Darien Gap Crossing
18 hours ago
Desis Decide Summit: Kamala Harris Encourages Indian-Americans to Boost Political Engagement
19 hours ago
Jagan Mohan Reddy confident of YSRCP retaining power with more seats than 2019 tally
19 hours ago
Chinese marketplace Temu under scanner for breaching EU's Digital Services Act
19 hours ago
Indian pilot to tour space on Blue Origin's next flight on May 19
19 hours ago
'iPad campaign was a major fumble': Tim Cook to 22-yr-old Indian student